TP53 and gastric cancer: Studies have demonstrated that silencing or overexpression of ACK enhanced or diminished levels of ubiquitination of p53 in gastric cancer (GC) cells, leading to degradation or increased stability of the tumour suppressor (Figure 2) [71,72].